Older persons, representing more than 10% of the population in the United States, take all forms of medication more frequently than younger individuals . Estimates of psychotropic drug use in the aged range from 7% to 92% in institutional settings and up to 30% in medical settings. A greater incidence of polypharmacy accompanies increased utilization of drugs . A recent survey in general hospitals showed that older patients received an average of 5–12 medications per day. These statistics reflect many factors: a longer life span accompanied by a greater incidence of chronic illnesses; increased medical sophistication; and drug therapy as a substitute for nonbiological interventions.


Orthostatic Hypotension Disruptive Behavior Psychotropic Drug Antipsychotic Medication Extrapyramidal Symptom 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Selected Reading

  1. 1.
    Salzman C.: Clinical Geriatric Psychopharmacology. McGraw-Hill, 1984.Google Scholar
  2. 2.
    Salzman C., Lebowitz B. (eds): Anxiety in the Elderly. New York, Springer, 1990.Google Scholar
  3. 3.
    Salzman C.: Practical considerations on the pharmacologic treatment of depression and anxiety in the elderly. J Clin Psychiatry 51(Suppl):40–43, 1990.PubMedGoogle Scholar
  4. 4.
    Glassman R., Salzman C.: Interactions between psychotropic and other drugs: An update. Hospital and Community Psychiatry 38:236–242, 1987.PubMedGoogle Scholar
  5. 5.
    Salzman C.: Treatment of the elderly agitated patient. J Clin Psychiatry 48(Suppl):19–22, 1987.PubMedGoogle Scholar
  6. 6.
    Salzman C.: Treatment of agitation in the elderly, in Meltzer H.Y. (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp. 1167–1176.Google Scholar
  7. 7.
    Salzman C.: Treatment of the agitated demented elderly patient. Hospital and Community Psychiatry 39:1143–1144, 1988.PubMedGoogle Scholar
  8. 8.
    Rosebush P., Salzman C.: Memory disturbance and cognitive impairment in the elderly, in Tupin J. P., Shader R. I., Harnett D. S. (eds): Handbook of Clinical Psychopharmacology, ed 2. New Northvale, New Jersey, London, Jason Aronson, 1988, pp. 159–210.Google Scholar
  9. 9.
    Salzman C.: Treatment of the depressed elderly patient, in Altman H. J. (ed): Alzheimer’s Disease and Dementia: Problems, Prospects and Perspectives. New York, Plenum Press, 1987, pp. 171–182.Google Scholar
  10. 10.
    Liptzin B., Salzman C.: Psychiatric aspects of aging, in Rowe J. R., Besdene R. (eds): Geriatric Medicine, ed 2. Boston, Little, Brown, 1988.Google Scholar
  11. 11.
    Berezin M., Liptzin B., Salzman C.: Geriatric psychiatry, in Nicholi A. (ed): Harvard Guide to Modern Psychiatry, ed 2. Cambridge, Harvard University Press, 1988.Google Scholar
  12. 12.
    Salzman C.: Treatment of agitation, anxiety, and depression in dementia. Psychopharmacology Bulletin 24:139–142, 1988.Google Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Carl Salzman
    • 1
    • 2
  1. 1.Department of PsychiatryHarvard Medical SchoolBostonUSA
  2. 2.Department of PsychopharmacologyMassachusetts Mental Health CenterBostonUSA

Personalised recommendations